DARPA

Two new projects announced last week will showcase organ-on-chip technology developed at the Wyss Institute.

The scientists will use gut-on-a-chip technology to develop probiotics that can sense and respond to pathogenic microbes that have made their way into a person's GI  system.

NEW YORK (GenomeWeb) – Scientists at the Scripps Research Institute's campuses in California and Florida have received $7.9 million from the Defense Advanced Research Projects Agency to create an "artificial immune system," or molecular libraries and compounds that can be used to detect and neutr

NEW YORK (GenomeWeb News) – Synthetic DNA manufacturing firm Twist Bioscience today announced it has raised $26 million in a Series B financing round and received a $5.1 million federal grant to further develop the company's technology platform.

NEW YORK (GenomeWeb News) – Vanderbilt University said that it has been awarded a cooperative agreement for up to $16.5 million to develop mass spectrometry-based methods to determine the effect of toxic agents on human cells.

NEW YORK (GenomeWeb News) — A research team at the University of Colorado, Boulder has received $14.6 million from the Defense Advanced Research Projects Agency to develop a system that will use microfluidics and mass spectrometry to determine how drugs and biological or chemical agents affect hu

A public-private research team spearheaded by GE Global Research and the University of Washington is six months into a $9.6 million, 18-month grant from the Defense Advanced Research Projects Agency to develop an integrated, handheld molecular diagnostic platform for use at the p

NEW YORK (GenomeWeb News) – The University of Washington has landed a $9.6 million award from the US Department of Defense.

This article contains a correction regarding funding to Harvard University and Stanford University.

Pages

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.